本页面由Tiger Trade Technology Pte. Ltd.提供服务

Fulcrum Therapeutics

3.68
-0.0700-1.87%
盘后:3.680.00000.00%19:30 EDT
成交量:145.71万
成交额:538.70万
市值:2.81亿
市盈率:-3.04
高:3.75
开:3.75
低:3.68
收:3.75
52周最高:15.74
52周最低:2.83
股本:7,629.73万
流通股本:6,349.06万
量比:0.93
换手率:2.29%
股息:- -
股息率:- -
每股收益(TTM):-1.2104
每股收益(LYR):-1.1819
净资产收益率:-32.38%
总资产收益率:-19.59%
市净率:0.90
市盈率(LYR):-3.11

数据加载中...

2023/10/03

重要事件披露

Form 8-K - Current report
2023/08/22

重要事件披露

Form 8-K - Current report
2023/08/03

重要事件披露

Form 8-K - Current report
2023/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/11

重要事件披露

Form 8-K - Current report
2023/06/26

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/06/26

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/06/24

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/06/10

重要事件披露

Form 8-K - Current report
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/15

重要事件披露

Form 8-K - Current report
2023/04/05

重要事件披露

8-K - Current report
2023/03/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/09

重要事件披露

8-K - Current report
2023/03/09

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/06

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals